左主干支架 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Left-main restenosis in the DES era-a call for action
Current Interventions for the Left Main Bifurcation
One or two stents for the distal Left Main bifurcation The DK crush V study - The DK crush V study
Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial
Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study
Left Main Revascularization in 2017 Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?
Design and rationale for the treatment effects of provisional side branch stenting and DK crush stenting techniques in patients with unprotected distal left main coronary artery bifurcation lesions (DKCRUSH V) Trial
Stent fracture is associated with a higher mortality in patients with type-2 diabetes treated by implantation of a second-generation drug-eluting stent
Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study
Contemporary Approach to Coronary Bifurcation Lesion Treatment

|<< 1 2 3 4 5 6 7 ...>>|

Review Article

2017 Nov 10 [Epub ahead of print]

JOURNAL：Cardiovasc Revasc Med.

Article Link

Left-main restenosis in the DES era-a call for action

di Palma G, Cortese B

26701

Keywords: In-stent restenosis; Sirolimus-coated balloon; Unprotected left main

ABSTRACT

Percutaneous treatment of the unprotected left main trunk (ULM), defined as a vessel without patent bypass graft either to the left circumflex (LCX) or left anterior descending (LAD) artery, has gained a precise role thanks to recent scientific evidence. Although new generation drug-eluting stents have already proven to be safer, there is still a consistent risk of restenosis and late adverse events. The optimal management of a ULM restenosis is still debated. Here we aim at presenting a review of the available data in literature and show our choice for treating it.